Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1983 5
1984 5
1985 3
1986 6
1987 1
1988 2
1989 2
1990 7
1991 11
1992 1
1993 7
1994 15
1995 4
1996 9
1997 15
1998 7
1999 6
2000 8
2001 15
2002 12
2003 17
2004 20
2005 21
2006 12
2007 32
2008 25
2009 28
2010 36
2011 36
2012 32
2013 45
2014 48
2015 61
2016 73
2017 54
2018 50
2019 35
2020 45
2021 48
2022 55
2023 50
2024 17

Text availability

Article attribute

Article type

Publication date

Search Results

902 results

Results by year

Filters applied: . Clear all
Page 1
Targeted Therapy and Checkpoint Immunotherapy in Lung Cancer.
Ruiz-Cordero R, Devine WP. Ruiz-Cordero R, et al. Surg Pathol Clin. 2020 Mar;13(1):17-33. doi: 10.1016/j.path.2019.11.002. Surg Pathol Clin. 2020. PMID: 32005431 Review.
Lung cancer is the leading cause of cancer mortality. It is classified into different histologic subtypes, including adenocarcinoma, squamous carcinoma, and large cell carcinoma (commonly referred as non-small cell lung …
Lung cancer is the leading cause of cancer mortality. It is classified into different histologic subtypes, including adenocarcinoma, …
Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.
Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Molina JR, et al. Mayo Clin Proc. 2008 May;83(5):584-94. doi: 10.4065/83.5.584. Mayo Clin Proc. 2008. PMID: 18452692 Free PMC article. Review.
Non-small cell lung cancer accounts for 85% of all lung cancer cases in the United States. ...We identified studies for this review by searching the MEDLINE and PubMed databases for English-language articles published from January 1, 1980, throu …
Non-small cell lung cancer accounts for 85% of all lung cancer cases in the United States. ...We identifi …
SMARCA4/BRG1-Deficient Non-Small Cell Lung Carcinomas: A Case Series and Review of the Literature.
Nambirajan A, Singh V, Bhardwaj N, Mittal S, Kumar S, Jain D. Nambirajan A, et al. Arch Pathol Lab Med. 2021 Jan 1;145(1):90-98. doi: 10.5858/arpa.2019-0633-OA. Arch Pathol Lab Med. 2021. PMID: 33367658 Free article. Review.
.-: Somatic mutations in SMARCA4 (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 4) gene and/or BRG1 (Brahma-related gene 1) loss identifies a subset of non-small cell lung carcinomas (NSCLCs) lac …
.-: Somatic mutations in SMARCA4 (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 4) gene an …
Squamous cell lung cancer: Current landscape and future therapeutic options.
Lau SCM, Pan Y, Velcheti V, Wong KK. Lau SCM, et al. Cancer Cell. 2022 Nov 14;40(11):1279-1293. doi: 10.1016/j.ccell.2022.09.018. Epub 2022 Oct 20. Cancer Cell. 2022. PMID: 36270277 Free article. Review.
Squamous cell lung cancers (lung squamous cell carcinomas [LUSCs]) are associated with high mortality and a lack of therapies specific to this disease. Although recurrent molecular aberrations are present in LUSCs, efforts to devel …
Squamous cell lung cancers (lung squamous cell carcinomas [LUSCs]) are associated with high …
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.
Hendry S, Salgado R, Gevaert T, Russell PA, John T, Thapa B, Christie M, van de Vijver K, Estrada MV, Gonzalez-Ericsson PI, Sanders M, Solomon B, Solinas C, Van den Eynden GGGM, Allory Y, Preusser M, Hainfellner J, Pruneri G, Vingiani A, Demaria S, Symmans F, Nuciforo P, Comerma L, Thompson EA, Lakhani S, Kim SR, Schnitt S, Colpaert C, Sotiriou C, Scherer SJ, Ignatiadis M, Badve S, Pierce RH, Viale G, Sirtaine N, Penault-Llorca F, Sugie T, Fineberg S, Paik S, Srinivasan A, Richardson A, Wang Y, Chmielik E, Brock J, Johnson DB, Balko J, Wienert S, Bossuyt V, Michiels S, Ternes N, Burchardi N, Luen SJ, Savas P, Klauschen F, Watson PH, Nelson BH, Criscitiello C, O'Toole S, Larsimont D, de Wind R, Curigliano G, André F, Lacroix-Triki M, van de Vijver M, Rojo F, Floris G, Bedri S, Sparano J, Rimm D, Nielsen T, Kos Z, Hewitt S, Singh B, Farshid G, Loibl S, Allison KH, Tung N, Adams S, Willard-Gallo K, Horlings HM, Gandhi L, Moreira A, Hirsch F, Dieci MV, Urbanowicz M, Brcic I, Korski K, Gaire F, Koeppen H, Lo A, Giltnane J, Rebelatto MC, Steele KE, Zha J, Emancipator K, Juco JW, Denkert C, Reis-Filho J, Loi S, Fox SB. Hendry S, et al. Adv Anat Pathol. 2017 Nov;24(6):311-335. doi: 10.1097/PAP.0000000000000161. Adv Anat Pathol. 2017. PMID: 28777143 Free PMC article. Review.
In part 1 of this review, we have proposed a standardized methodology to assess tumor-infiltrating lymphocytes (TILs) in solid tumors, based on the International Immuno-Oncology Biomarkers Working Group guidelines for invasive breast carcinoma. In part 2 of this review, we …
In part 1 of this review, we have proposed a standardized methodology to assess tumor-infiltrating lymphocytes (TILs) in solid tumors, based …
Exploiting the folate receptor α in oncology.
Scaranti M, Cojocaru E, Banerjee S, Banerji U. Scaranti M, et al. Nat Rev Clin Oncol. 2020 Jun;17(6):349-359. doi: 10.1038/s41571-020-0339-5. Epub 2020 Mar 9. Nat Rev Clin Oncol. 2020. PMID: 32152484 Review.
Binding to FRalpha is one of several methods by which folate is taken up by cells; however, this receptor is an attractive anticancer drug target owing to the overexpression of FRalpha in a range of solid tumours, including ovarian, lung and breast cancers. Furtherm …
Binding to FRalpha is one of several methods by which folate is taken up by cells; however, this receptor is an attractive anticancer …
Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials.
Niu Z, Jin R, Zhang Y, Li H. Niu Z, et al. Signal Transduct Target Ther. 2022 Oct 5;7(1):353. doi: 10.1038/s41392-022-01200-x. Signal Transduct Target Ther. 2022. PMID: 36198685 Free PMC article. Review.
Lung cancer is the leading cause of cancer-related death across the world. Unlike lung adenocarcinoma, patients with lung squamous cell carcinoma (LSCC) have not benefitted from targeted therapies. ...
Lung cancer is the leading cause of cancer-related death across the world. Unlike lung adenocarcinoma, patients with lung …
Abandoning the Notion of Non-Small Cell Lung Cancer.
Relli V, Trerotola M, Guerra E, Alberti S. Relli V, et al. Trends Mol Med. 2019 Jul;25(7):585-594. doi: 10.1016/j.molmed.2019.04.012. Epub 2019 May 30. Trends Mol Med. 2019. PMID: 31155338 Review.
Non-small cell lung cancers (NSCLCs) represent 85% of lung tumors. NSCLCs encompass multiple cancer types, such as adenocarcinomas (LUADs), squamous cell cancers (LUSCs), and large cell cancers. Among them, LUADs and LUSCs a …
Non-small cell lung cancers (NSCLCs) represent 85% of lung tumors. NSCLCs encompass multiple cancer types …
Progress and prospects of early detection in lung cancer.
Blandin Knight S, Crosbie PA, Balata H, Chudziak J, Hussell T, Dive C. Blandin Knight S, et al. Open Biol. 2017 Sep;7(9):170070. doi: 10.1098/rsob.170070. Open Biol. 2017. PMID: 28878044 Free PMC article. Review.
It is broadly divided into small cell (SCLC, approx. 15% cases) and non-small cell lung cancer (NSCLC, approx. 85% cases). The main histological subtypes of NSCLC are adenocarcinoma and squamous cell carcinoma, with the pres …
It is broadly divided into small cell (SCLC, approx. 15% cases) and non-small cell lung cancer (NSCLC, ap …
Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin.
Oser MG, Niederst MJ, Sequist LV, Engelman JA. Oser MG, et al. Lancet Oncol. 2015 Apr;16(4):e165-72. doi: 10.1016/S1470-2045(14)71180-5. Lancet Oncol. 2015. PMID: 25846096 Free PMC article. Review.
Lung cancer is the most common cause of cancer deaths worldwide. The two broad histological subtypes of lung cancer are small-cell lung cancer (SCLC), which is the cause of 15% of cases, and non-small-cell lung cancer (NSCLC …
Lung cancer is the most common cause of cancer deaths worldwide. The two broad histological subtypes of lung cancer are small- …
902 results